These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7937148)

  • 21. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
    Singh H; Sen R; Baltimore D; Sharp PA
    Nature; 1986 Jan 9-15; 319(6049):154-8. PubMed ID: 3079885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription.
    Su LK; Kadesch T
    Mol Cell Biol; 1990 Jun; 10(6):2619-24. PubMed ID: 2111440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two regulatory elements for immunoglobulin kappa light chain gene expression.
    Bergman Y; Rice D; Grosschedl R; Baltimore D
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7041-5. PubMed ID: 6438631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-gamma induces the kappa intron enhancer via an IFN-stimulated response element.
    Damore MA; Omori SA; Wall R
    J Immunol; 1996 Apr; 156(7):2451-7. PubMed ID: 8786304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci.
    Inlay MA; Lin T; Gao HH; Xu Y
    J Exp Med; 2006 Jul; 203(7):1721-32. PubMed ID: 16785310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-lymphocyte targeting of gene expression in transgenic mice with the immunoglobulin heavy-chain enhancer.
    Gerlinger P; LeMeur M; Irrmann C; Renard P; Wasylyk C; Wasylyk B
    Nucleic Acids Res; 1986 Aug; 14(16):6565-77. PubMed ID: 3092186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mouse and rabbit Ei kappa enhancers indicates that different elements within the enhancer may mediate activation of transcription and recombination.
    Coquilleau I; Cavelier P; Rougeon F; Goodhardt M
    J Immunol; 2000 Jan; 164(2):795-804. PubMed ID: 10623825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin kappa gene enhancers synergistically activate gene expression but independently determine chromatin structure.
    Blasquez VC; Hale MA; Trevorrow KW; Garrard WT
    J Biol Chem; 1992 Nov; 267(33):23888-93. PubMed ID: 1429727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.
    Nikolajczyk BS; Sardi SH; Tumang JR; Ganley-Leal LM
    Mol Immunol; 2007 Jul; 44(13):3407-15. PubMed ID: 17382392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
    Currie RA; Roeder RG
    Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3' enhancer.
    Grant PA; Arulampalam V; Ahrlund-Richter L; Pettersson S
    Nucleic Acids Res; 1992 Sep; 20(17):4401-8. PubMed ID: 1408741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus.
    Lieberson R; Giannini SL; Birshtein BK; Eckhardt LA
    Nucleic Acids Res; 1991 Feb; 19(4):933-7. PubMed ID: 1901991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins.
    Michaelson JS; Singh M; Snapper CM; Sha WC; Baltimore D; Birshtein BK
    J Immunol; 1996 Apr; 156(8):2828-39. PubMed ID: 8609402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
    Roque MC; Smith PA; Blasquez VC
    Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an octamer-binding site in the human kappa light-chain enhancer.
    Nelms K; Van Ness B
    Mol Cell Biol; 1990 Jul; 10(7):3843-6. PubMed ID: 2113179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organization of the transcription factor binding sites in the kappa Ig intron enhancer. Effects of position, orientation, and spacing.
    Schanke JT; Van Ness BG
    J Immunol; 1994 Nov; 153(10):4565-72. PubMed ID: 7963528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of antibody cDNA in murine myeloma cells: possible involvement of additional regulatory elements in transcription of immunoglobulin genes.
    Weidle UH; Koch S; Buckel P
    Gene; 1987; 60(2-3):205-16. PubMed ID: 3127273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.
    Inlay MA; Gao HH; Odegard VH; Lin T; Schatz DG; Xu Y
    J Immunol; 2006 Jul; 177(2):1146-51. PubMed ID: 16818772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
    Geltinger C; Hörtnagel K; Polack A
    Gene Expr; 1996; 6(2):113-27. PubMed ID: 8979089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.